Postpartum Depression: Treatment Options Beyond SSRIs

Becoming a mother is supposed to be one of the most joyful experiences of a woman's life. When postpartum depression (PPD) strikes instead, the gap between expectation and reality can be devastating — and the shame and confusion that often accompany it can prevent women from seeking the help they need and deserve.

Postpartum depression is not a character flaw, a sign of weakness, or evidence that you're a bad mother. It is a medical condition with identifiable biological causes — and it is highly treatable.

At Roth Family Medicine & Mental Health in Pocatello, Idaho, we take postpartum depression seriously and offer a comprehensive range of treatment options that go well beyond the standard SSRI prescription.

Postpartum depression affects approximately 1 in 7 new mothers — making it the most common complication of childbirth. Despite its prevalence, it remains dramatically undertreated:

• Only about 15% of women with PPD receive any professional treatment
• Many women don't recognize their symptoms as PPD
• Stigma prevents many from disclosing symptoms to their providers
• Screening is inconsistent — many women are never asked about mood symptoms after delivery

The consequences of untreated PPD extend beyond the mother. Research consistently shows that maternal depression negatively affects infant attachment, cognitive development, and long-term child mental health outcomes. Treating PPD is not just about the mother — it's about the whole family.

PPD is not simply "baby blues" that persist. It is a distinct clinical condition with specific biological drivers:

During pregnancy, estrogen and progesterone levels rise to extraordinary heights — 10–100 times their normal levels. In the days following delivery, these hormones plummet precipitously. For women who are neurobiologically sensitive to hormonal fluctuations, this crash can trigger a depressive episode.

Progesterone is particularly relevant: it metabolizes into allopregnanolone, a potent positive modulator of GABA receptors that has anxiolytic and mood-stabilizing effects. The rapid loss of allopregnanolone after delivery is now understood to be a central mechanism in PPD — and it's the basis for the first FDA-approved PPD-specific treatment (brexanolone/Zulresso).

Postpartum thyroiditis — inflammation of the thyroid gland after delivery — affects 5–10% of women and can cause either hyperthyroidism or hypothyroidism. Both can produce mood symptoms that mimic or worsen PPD. Thyroid function should be checked in all women with postpartum mood symptoms.

The profound sleep deprivation of new parenthood is not just exhausting — it is neurobiologically destabilizing. Sleep deprivation elevates cortisol, disrupts HPA axis regulation, reduces serotonin and dopamine, and impairs prefrontal cortex function. For women already vulnerable to PPD, sleep deprivation can be the tipping point.

Pregnancy and breastfeeding are nutritionally demanding. Deficiencies in omega-3 fatty acids (particularly DHA), iron, vitamin D, B12, folate, and zinc are common postpartum and all contribute to mood dysregulation.

Biological vulnerability is amplified by psychosocial stressors: relationship strain, financial stress, lack of social support, history of trauma or depression, difficult birth experiences, and the identity disruption of new parenthood.

PPD typically develops within the first 4 weeks after delivery but can emerge any time in the first year. Symptoms include:

• Persistent sadness, emptiness, or hopelessness
• Loss of interest or pleasure in activities, including caring for the baby
• Difficulty bonding with the baby
• Excessive crying
• Withdrawing from family and friends
• Changes in appetite and sleep (beyond normal newborn disruption)
• Overwhelming fatigue
• Difficulty concentrating or making decisions
• Intense anxiety, panic attacks
• Thoughts of harming yourself or the baby (requires immediate evaluation)
• Feelings of worthlessness, guilt, or shame about being a "bad mother"

Baby blues — mild mood fluctuations, tearfulness, and anxiety in the first 1–2 weeks after delivery — are normal and typically resolve on their own. PPD is distinguished by greater severity, longer duration (beyond 2 weeks), and significant functional impairment.

Postpartum anxiety is equally common as PPD and often co-occurs with it. Postpartum OCD (intrusive thoughts about harming the baby) and postpartum psychosis (a psychiatric emergency) are less common but require prompt recognition and treatment.

Sertraline (Zoloft) and escitalopram (Lexapro) are the most commonly prescribed SSRIs for PPD and are considered safe during breastfeeding. They are effective for many women, but:

• Onset of action is 4–6 weeks
• 30–40% of patients don't achieve adequate response to the first SSRI
• Side effects (sexual dysfunction, weight gain, emotional blunting) are common
• They don't address the underlying hormonal or nutritional drivers

SSRIs are a reasonable first-line option for many women, but they are not the only option — and for women who need faster relief or have failed SSRIs, other approaches are essential.

Brexanolone is a synthetic form of allopregnanolone — the neurosteroid that plummets after delivery. It is the first and only FDA-approved treatment specifically for PPD.

Administered as a 60-hour IV infusion in a certified healthcare facility, brexanolone produces rapid, dramatic improvement in PPD symptoms — often within 24–48 hours. In clinical trials, 70–75% of women achieved remission.

The main limitations are cost, the requirement for inpatient administration, and limited availability. Zuranolone (Zurzuvae), an oral form of allopregnanolone, received FDA approval in 2023 and is more accessible — a 14-day course of oral pills.

Given that PPD is fundamentally driven by hormonal changes, hormonal interventions are logical and often effective:

Estrogen therapy: Transdermal estradiol has been shown in clinical trials to significantly reduce PPD symptoms. It is particularly relevant for women with severe hormonal sensitivity or those who have failed antidepressants.

Progesterone/progestins: More complex — synthetic progestins can worsen mood in some women, while natural progesterone (particularly its allopregnanolone metabolite) is beneficial. Bioidentical progesterone is preferred.

Thyroid optimization: For women with postpartum thyroiditis or subclinical hypothyroidism, thyroid hormone replacement can resolve mood symptoms that appear to be PPD.

At our practice, we evaluate the full hormonal picture — estrogen, progesterone, testosterone, thyroid, and cortisol — in women with PPD, particularly those who haven't responded to standard treatments.

Omega-3 fatty acids (EPA/DHA): Multiple studies support omega-3 supplementation for PPD. DHA is particularly important for brain function and is depleted by pregnancy and breastfeeding. Doses of 1–2g EPA/DHA daily are typically recommended.

Iron: Postpartum iron deficiency is extremely common and produces fatigue, cognitive impairment, and mood symptoms that can be mistaken for or worsen PPD. Iron levels should be checked and repleted as needed.

Vitamin D: Deficiency is common in Idaho (limited sun exposure, especially in winter) and is associated with depression. Supplementation to optimal levels (50–80 ng/mL) is often beneficial.

B vitamins: B12, folate, and B6 are essential for neurotransmitter synthesis. Deficiencies are common postpartum, especially in women who were depleted during pregnancy.

Cognitive behavioral therapy (CBT): Strong evidence for PPD. Addresses the negative thought patterns, perfectionism, and identity disruption common in new mothers.

Interpersonal therapy (IPT): Specifically designed for PPD. Focuses on role transitions, relationship changes, and building social support.

Mother-infant therapy: Addresses the attachment relationship between mother and baby, which can be disrupted by PPD.

Therapy is most effective when combined with biological treatments — addressing both the neurobiological and psychological dimensions of PPD.

For women with severe PPD, treatment-resistant PPD, or PPD with significant suicidal ideation, ketamine therapy offers rapid relief that standard treatments cannot match.

Ketamine's mechanism — rapid synaptogenesis, BDNF upregulation, and glutamate system normalization — directly addresses the neurobiological damage caused by the hormonal crash and sleep deprivation of the postpartum period.

Important note on breastfeeding: Ketamine is excreted in breast milk. Women who wish to continue breastfeeding should discuss the risks and benefits with their provider. Many women choose to temporarily pause breastfeeding during a ketamine treatment series given the severity of their symptoms.

Transcranial magnetic stimulation (TMS) is non-invasive, has no systemic side effects, and is safe during breastfeeding — making it an attractive option for postpartum women who want to avoid medications. TMS has strong evidence for major depression and is increasingly used for PPD.

Social support is one of the strongest protective factors against PPD. Practical interventions include:

• Postpartum Doulas: Provide practical support and allow the mother to sleep
• Support groups: Connecting with other mothers experiencing PPD reduces isolation and shame
• Partner involvement: Educating partners about PPD and enlisting their active support
• Respite care: Ensuring the mother gets adequate sleep, even if this means formula supplementation

Postpartum psychosis is a psychiatric emergency that requires immediate evaluation. Signs include:

• Hallucinations (hearing or seeing things that aren't there)
• Delusions (fixed false beliefs, often about the baby)
• Rapid mood swings
• Confusion and disorientation
• Bizarre behavior

If you or someone you know is experiencing these symptoms, call 911 or go to the nearest emergency room immediately.

Suicidal thoughts or thoughts of harming the baby also require immediate evaluation. Please call or text 988 (Suicide and Crisis Lifeline) or go to your nearest emergency room.

If you're a new mother in Pocatello, Chubbuck, Bannock County, or Southeast Idaho experiencing symptoms of postpartum depression, please reach out. You don't have to suffer through this alone, and you don't have to settle for a treatment that isn't working.

At Roth Family Medicine & Mental Health, we offer comprehensive evaluation and a full range of treatment options for postpartum depression — from nutritional and hormonal assessment to ketamine therapy and TMS.

Call us at (208) 904-4705 or book online. We're accepting new patients and are committed to supporting mothers through one of the most challenging experiences of their lives.

• Postpartum depression affects 1 in 7 mothers and is vastly undertreated
• The hormonal crash after delivery — particularly the loss of allopregnanolone — is a central biological driver
• Treatment options extend well beyond SSRIs: brexanolone/zuranolone, hormonal therapy, nutritional interventions, ketamine, TMS, and psychotherapy
• Thyroid function should be checked in all women with postpartum mood symptoms
• Omega-3 fatty acids, iron, vitamin D, and B vitamins are commonly depleted postpartum and should be assessed
• Postpartum psychosis is a psychiatric emergency requiring immediate evaluation
• Effective treatment of PPD benefits not just the mother but the entire family

Kyle Roth, FNP-BC, APRN, MSN, MHA is a board-certified family nurse practitioner specializing in women's mental health, hormone therapy, and integrative mental health care at Roth Family Medicine & Mental Health in Pocatello, Idaho.

This article is for informational purposes only and does not constitute medical advice. If you are experiencing thoughts of harming yourself or your baby, please seek emergency care immediately.